Nasal/buccal midazolam use in the community

Archives of Disease in Childhood

Volumn 89, Issue 1, 2004, Pages 50-51

  Wilson, M T ^a   Macleod, S ^a   O'Regan, M E ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; MIDAZOLAM;

ADOLESCENT; ADULT; AWARENESS; CHILD; COMMUNITY; DRUG CHOICE; DRUG EFFICACY; DRUG USE; EPILEPTIC STATE; HEALTH SURVEY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SALIVA; SEIZURE; SOCIAL ASPECT; TELEPHONE;

ADMINISTRATION, BUCCAL; ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MIDAZOLAM; SEIZURES;

EID: 1642540114     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2002.019836     Document Type: Review

References (5)

1. Kendal JL, Reynolds M, Goldberg R. Intranasal midazolam in patients with status epilepticus. Annf Emerg Med 1997;29:415-17.
2. Malinovsky J-M, Lejus C, Servin F, et al. Plasma concentrations of midazolam after IV, rectal or nasal administration in children. Br J Anaesth 1993;70:617-20.
3. Connors K, Tendrup TE. Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair. Ann Emerg Med 1994:245.
4. O'Regan ME, Brown JR, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol 1996;38:1037-45.
5. Scott RC, Besag FMC, Neville BGR. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999;353:623-6.